Notably, recurrent deletions of COL12A1 have been identified in primary central nervous system lymphoma [43], and thus we now have identified a second B cell lymphoma with recurrent genetic alterations of this gene. This evidence concerns the gene COL12A1 and primary central nervous system lymphoma.